Secukinumab side effects?

Common Side Effects of Secukinumab

Secukinumab, marketed under the brand name Cosentyx, is a biologic medication used to treat psoriasis, psoriatic arthritis, ankylosing spondylitis, and plaque psoriasis. Like all medications, it can cause side effects [1].

According to the FDA, common side effects of secukinumab include [2]:

* Headache
* Injection site reactions (redness, swelling, pain, or itching)
* Fatigue
* Musculoskeletal pain
* Nausea
* Diarrhea
* Upper respiratory infections (such as the common cold or flu)

Infrequent but Serious Side Effects

While rare, some patients have experienced more severe side effects while taking secukinumab, including:

* Serious infections (such as sepsis or tuberculosis)
* Blood clots or deep vein thrombosis
* Increased liver enzyme levels (indicating potential liver damage)
* Pancreatitis (inflammation of the pancreas)
* Hypersensitivity reactions (ranging from mild to severe)
* Arterial thromboembolism (blockage of an artery)

Precautions and Patient Safety

Patients with certain medical conditions, such as a weakened immune system, or those taking specific medications, may be at increased risk for side effects [3]. Patients should inform their healthcare provider about any prior medical conditions or current medications they are taking.

Monitoring and Dosing

To minimize side effects, patients on secukinumab should be closely monitored by their healthcare provider, especially during the first few weeks of treatment. It is essential to follow the recommended dosing schedule and report any adverse effects promptly.

Clinical Trials and Research

Studies have demonstrated a good safety profile for secukinumab in patients with various diseases [4]. However, as with any medication, there is a potential for rare but serious side effects.

Regulatory Status and Availability

Secukinumab is an FDA-approved medication and is available in the United States under the brand name Cosentyx. It is available through various channels, including pharmacies and online retailers [5].

Citations:

[1] - FDA.gov: Cosentyx (secukinumab) Injection, for subcutaneous use
[2] - Cosentyx (secukinumab) Patient Information
[3] - Cosentyx (secukinumab).org - Adverse reactions
[4] - Clinical trials for Cosentyx (secukinumab) on ClinicalTrials.gov
[5] - DrugPatentWatch.com: Secukinumab patents and availability

Please consult the official sources for the most accurate and up-to-date information regarding secukinumab.